American Tech Today
SEE OTHER BRANDS

Hottest science and technology news from the United States

American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on May 19, 2025

MIGNOW Announces Entry into U.S. Market to Accelerate SAP S/4HANA Migration Through AI Automation

MIGNOW Announces Entry into U.S. Market to Accelerate SAP S/4HANA Migration Through AI Automation

Methodology Cuts Migration Timelines up to 5X, Reduces Project Costs as much as 70% versus Traditional Approaches MIAMI, May 19, 2025 (GLOBE NEWSWIRE) -- MIGNOW, a leading provider of AI-driven software migration solutions, today announced its official …

Astera Labs Expands Collaboration with NVIDIA to Advance NVLink Fusion Ecosystem

Astera Labs Expands Collaboration with NVIDIA to Advance NVLink Fusion Ecosystem

SANTA CLARA, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced it is collaborating with NVIDIA to provide scale-up …

Floyi Releases SaaS Content Marketing Guide for 2025 Success

Floyi Releases SaaS Content Marketing Guide for 2025 Success

Offers a field-tested playbook for mapping markets, aligning content with buyer stages and leveraging SEO, GEO and AI tactics NEW YORK, NY, UNITED STATES, May 18, 2025 /⁨EINPresswire.com⁩/ -- Floyi today released its SaaS Content Marketing Guide for 2025 …

Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy

Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy

--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder. Regulatory approval for the …

Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading

Tyveo Exchange Partners with WAF: Igniting a New Spark in Stock and Crypto Trading

New York, NY, May 19, 2025 (GLOBE NEWSWIRE) -- In the rapidly evolving global financial landscape, the convergence of traditional finance and digital assets is emerging as a defining trend. Tyveo Exchange and WAF (WealthArc Fintech) have recently announced …

Mastermind Business System by Tony Robbins & Dean Graziosi Offers Framework for Building Knowledge-Based Businesses

Mastermind Business System by Tony Robbins & Dean Graziosi Offers Framework for Building Knowledge-Based Businesses

Mastermind Business System by Tony Robbins and Dean Graziosi helps individuals launch and grow knowledge-based businesses online. FL, UNITED STATES, May 18, 2025 /⁨EINPresswire.com⁩/ -- Following the recent conclusion of the Thrive in 2025 event, renowned …

KixaMiner: Increase your wealth with daily passive income through cloud mining

KixaMiner: Increase your wealth with daily passive income through cloud mining

Londond, United Kingdom, May 19, 2025 (GLOBE NEWSWIRE) -- As times change, so do attitudes toward energy. The rise of renewable energy sources like solar and wind power has revolutionized cloud mining operations—significantly reducing costs while feeding …

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, June 1, 2025, at 6:00 p.m. CT (7:00 p.m. ET) during the …

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, …

Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference

Windtree Therapeutics Announces Istaroxime Presentation at European Society of Cardiology Heart Failure Conference

WARRINGTON, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

Eascra Biotech Awarded $100,000 MassVentures START Grant

Eascra Biotech Awarded $100,000 MassVentures START Grant

BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and managed by MassVentures. The funding is to support their work on …

Respira Therapeutics Announces Late-breaking Presentation of RT234 Phase 2b PAH Clinical Trial Results at the American Thoracic Society (ATS) 2025 International Conference

Respira Therapeutics Announces Late-breaking Presentation of RT234 Phase 2b PAH Clinical Trial Results at the American Thoracic Society (ATS) 2025 International Conference

PALO ALTO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Respira Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing RT234 (vardenafil inhalation powder) as the first therapy that pulmonary arterial hypertension (PAH) patients …

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma

SOUTH SAN FRANCISCO, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that the first patient has been dosed with CX-801 in combination …

Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic Innovations

Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic Innovations

OREM, Utah, May 19, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a pioneer in cryogenic cooling technologies, today highlighted how its patented solutions are uniquely positioned to address the surging global demand for advanced data …

Vertex Named a Finalist for 2025 SAP® Pinnacle Award in the SAP Store Category

Vertex Named a Finalist for 2025 SAP® Pinnacle Award in the SAP Store Category

KING OF PRUSSIA, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced that it has been recognized by SAP as a finalist for a 2025 SAP® Pinnacle Award in …

Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)

Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to publish for the first time the assay results of historical deep diamond …

ViWo Starts Social Media Revolution as VCoin Presale Goes Live

ViWo Starts Social Media Revolution as VCoin Presale Goes Live

Kirkland, Washington, May 19, 2025 (GLOBE NEWSWIRE) -- SmarTech LLC, a USA-verified technology innovator with over 17 years of experience, announces the presale launch of ViWo, a revolutionary decentralized application (dApp). The event is live on the app' …

Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)

Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)

GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has enrolled the …

LIS Technologies Inc. to Unleash American Energy: Closing of Third Consecutive Oversubscribed Funding Round of $11.93M and Totaling Over $47M to Rebirth the Only United States Origin and Patented Technology for Laser Uranium Enrichment

LIS Technologies Inc. to Unleash American Energy: Closing of Third Consecutive Oversubscribed Funding Round of $11.93M and Totaling Over $47M to Rebirth the Only United States Origin and Patented Technology for Laser Uranium Enrichment

Oak Ridge, Tennessee, May 19, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has …

XORTX Announces USD $3 Million Offering

XORTX Announces USD $3 Million Offering

CALGARY, Alberta, May 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service